Published in Anesthesiology on June 01, 1979
Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function. Anesthesiology (2007) 1.13
A surgeon's assessment of inadequate neuromuscular antagonism in a case of prolonged neuromuscular blockade. J Anaesthesiol Clin Pharmacol (2013) 0.91
Neuromuscular blockade improves surgical conditions (NISCO). Surg Endosc (2014) 0.89
Residual Paralysis: Does it Influence Outcome After Ambulatory Surgery? Curr Anesthesiol Rep (2014) 0.82
Perioperative sleep apnea: a real problem or did we invent a new disease? F1000Res (2016) 0.77
Neuromuscular blocking drugs: practical aspects of research in the intensive care unit. Intensive Care Med (1993) 0.76
Monitoring of neuromuscular function in the clinical setting. Yale J Biol Med (1995) 0.75
Postoperative residual block in postanesthesia care unit more than two hours after the administration of a single intubating dose of atracurium. J Res Med Sci (2011) 0.75
Assessment of neuromuscular blockade using tetanic, single-twitch and train-of-four responses: discussion paper. J R Soc Med (1984) 0.75
Atropine or glycopyrrolate with neostigmine 5 mg: a comparative dose-response study. J R Soc Med (1986) 0.75
Monitoring, new drugs, and reversal of neuromuscular blocking drugs. Can J Anaesth (1991) 0.75
Abstracts: annual meeting of the Canadian Anesthetists' Society. June 26-29, 1988, Halifax, Nova Scotia. Can J Anaesth (1988) 0.75
A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology (1994) 3.23
Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand (2007) 2.77
A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anaesthesia (1997) 2.35
Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand (1997) 1.88
Double burst stimulation (DBS): a new pattern of nerve stimulation to identify residual neuromuscular block. Br J Anaesth (1989) 1.54
Identification of human plasma cholinesterase variants using molecular biological techniques. Acta Anaesthesiol Scand (1995) 1.47
Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat Genet (1993) 1.45
Does perioperative tactile evaluation of the train-of-four response influence the frequency of postoperative residual neuromuscular blockade? Anesthesiology (1990) 1.44
Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity. Acta Anaesthesiol Scand (1995) 1.39
Half-life of plasma cholinesterase. Acta Anaesthesiol Scand (1988) 1.25
Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology (1985) 1.14
Succinylcholine neuromuscular blockade in subjects homozygous for atypical plasma cholinesterase. Anesthesiology (1981) 1.09
Incidence of malignant hyperthermia in Denmark. Anesth Analg (1985) 1.08
Implementation of pharmaceutical practice guidelines. Anesthesiology (1997) 1.08
Post-operative recovery after laparoscopic cholecystectomy. Acta Anaesthesiol Scand (2007) 1.07
Clinical assessment of neuromuscular transmission. Br J Anaesth (1982) 1.06
Osteogenesis imperfecta and malignant hyperthermia. Is there a relationship? Anaesthesia (1996) 1.04
Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four. Anesthesiology (1989) 0.99
Scandinavian research in anaesthesiology 1981-2000: visibility and impact in EU and world context. Acta Anaesthesiol Scand (2004) 0.99
Relationship between posttetanic count and response to carinal stimulation during vecuronium-induced neuromuscular blockade. Acta Anaesthesiol Scand (1987) 0.98
Posttetanic count (PTC): a new method of evaluating an intense nondepolarizing neuromuscular blockade. Anesthesiology (1981) 0.98
Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation. Am J Hum Genet (1998) 0.96
The undesirable effects of neuromuscular blocking drugs. Anaesthesia (2009) 0.96
Bradycardia and cardiac asystole following a single injection of suxamethonium. Acta Anaesthesiol Scand (1984) 0.95
Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth (2000) 0.94
Sleep disturbances in critically ill patients in ICU: how much do we know? Acta Anaesthesiol Scand (2012) 0.93
Anaesthetic practice and postoperative pulmonary complications. Acta Anaesthesiol Scand (1992) 0.92
Prolonged apnoea after suxamethonium: an analysis of the first 225 cases reported to the Danish Cholinesterase Research Unit. Acta Anaesthesiol Scand (1978) 0.92
Remifentanil vs. alfentanil for direct laryngoscopy: a randomized study comparing two total intravenous anaesthesia techniques. TIVA for direct laryngoscopy. Acta Anaesthesiol Belg (2002) 0.91
Twitch tension and train-of-four ratio during prolonged neuromuscular monitoring at different peripheral temperatures. Acta Anaesthesiol Scand (1991) 0.90
Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients. Acta Anaesthesiol Scand (1992) 0.89
Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis. Acta Anaesthesiol Scand (1998) 0.88
Identification of human plasma cholinesterase variants in 6,688 individuals using biochemical analysis. Acta Anaesthesiol Scand (1995) 0.88
The Accelograph: a new neuromuscular transmission monitor. Acta Anaesthesiol Scand (1988) 0.87
Prolonged residual paralysis after a single intubating dose of rocuronium. Br J Anaesth (2007) 0.87
Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is used. Acta Anaesthesiol Scand (2002) 0.87
Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia. Br J Anaesth (1997) 0.87
Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with the genotypically normal enzyme. Anesthesiology (1980) 0.87
Evaluation of intense neuromuscular blockade caused by vecuronium using posttetanic count (PTC). Anesthesiology (1987) 0.87
Tactile evaluation of the posttetanic count (PTC). Anesthesiology (1984) 0.86
Csf and plasma morphine after epidural and intrathecal application. Anesthesiology (1981) 0.86
Relationship of post-tetanic count and train-of-four response during intense neuromuscular blockade caused by atracurium. Br J Anaesth (1987) 0.86
Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase. Br J Clin Pharmacol (1998) 0.85
A double-blind group comparative study using the new anti-depressant Org 3770, placebo and diazepam in patients with expected insomnia and anxiety before elective gynaecological surgery. Acta Psychiatr Scand (1985) 0.85
The pharmacodynamics and pharmacokinetics of mivacurium in children. Acta Anaesthesiol Scand (2002) 0.84
The effect of bambuterol (carbamylated terbutaline) on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in genotypically normal patients. Acta Anaesthesiol Scand (1990) 0.84
Risk factors, complications and outcome in anaesthesia. A pilot study. Eur J Anaesthesiol (1986) 0.83
Ca(2+)-ATPase and Na(+)-K(+)-ATPase content in skeletal muscle from malignant hyperthermia patients. Muscle Nerve (1992) 0.83
Influence of epidural morphine on postoperative pain, endocrine-metabolic, and renal responses to surgery. A controlled study. Acta Anaesthesiol Scand (1982) 0.83
Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg (1993) 0.83
Acceleromyography of the orbicularis oculi muscle II: comparing the orbicularis oculi and adductor pollicis muscles. Acta Anaesthesiol Scand (2002) 0.83
Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase. Acta Anaesthesiol Scand (1993) 0.82
How do anaesthesiologists treat malignant hyperthermia in a full-scale anaesthesia simulator? Acta Anaesthesiol Scand (2001) 0.82
Remifentanil vs. alfentanil infusion in non-paralysed patients: a randomized, double-blind study. Eur J Anaesthesiol (2004) 0.82
Postoperative pain control by epidural analgesia after transabdominal surgery. Efficacy and problems encountered in daily routine. Acta Anaesthesiol Scand (2000) 0.81
Serum cholinesterase activity in burned patients. I: biochemical findings. Acta Anaesthesiol Scand (1975) 0.81
Monitoring of the neuromuscular transmission by electromyography (I). Stability and temperature dependence of evoked EMG response compared to mechanical twitch recordings in the cat. Acta Anaesthesiol Scand (1992) 0.81
Plasma cholinesterase and abnormal reaction to succinylcholine: twenty years' experience with the Danish Cholinesterase Research Unit. Acta Anaesthesiol Scand (1995) 0.80
Arm-to-arm variation when evaluating neuromuscular block: an analysis of the precision and the bias and agreement between arms when using mechanomyography or acceleromyography. Br J Anaesth (2010) 0.80
[Testing of neuromuscular function during anaesthesia (author's transl)]. Anesth Analg (Paris) (1980) 0.80
Use of post-tetanic count in assessment of a repetitive vecuronium-induced neuromuscular block. Br J Anaesth (1990) 0.80
Precurarization--a hazard to the patient? Acta Anaesthesiol Scand (1984) 0.79
Can rocuronium replace succinylcholine in a rapid-sequence induction of anaesthesia? Acta Anaesthesiol Scand (1999) 0.79
Rapid simultaneous genotyping of the frequent butyrylcholinesterase variants Asp70Gly and Ala539Thr with fluorescent hybridization probes. Scand J Clin Lab Invest (2002) 0.79
The effect of bambuterol on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase. Acta Anaesthesiol Scand (1990) 0.79
A multicenter study of 4-chloro-m-cresol for diagnosing malignant hyperthermia susceptibility. Anesth Analg (2000) 0.79
Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA). Acta Anaesthesiol Scand (2003) 0.79
Cholinesterase and succinylcholine. Dan Med Bull (1983) 0.79
Catatonia after epidural morphine. Acta Anaesthesiol Scand (1981) 0.79
Comparison of the cardiovascular effects of cisatracurium and vecuronium in patients with coronary artery disease. Can J Anaesth (1998) 0.79
Efficacy of A-line AEP Monitor as a tool for predicting acceptable tracheal intubation conditions during sevoflurane anaesthesia. Br J Anaesth (2005) 0.78
Malignant hyperthermia triggered by heating in anaesthetized pigs. Acta Anaesthesiol Scand (1985) 0.78
The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium. Anesthesiology (2000) 0.78
Discordance between malignant hyperthermia susceptibility and RYR1 mutation C1840T in two Scandinavian MH families exhibiting this mutation. Clin Genet (1997) 0.78
Reproducibility of in vitro contracture test results in patients tested for malignant hyperthermia susceptibility. Acta Anaesthesiol Scand (2002) 0.78
Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase. Anesthesiology (1995) 0.78
Clinical variability of possible malignant hyperthermia as revealed by two cases. Acta Anaesthesiol Belg (1994) 0.78
A new nerve stimulator (Myotest). Br J Anaesth (1980) 0.78
RYR mutation G1021A (Gly341Arg) is not frequent in Danish and Swedish families with malignant hyperthermia susceptibility. Clin Genet (1996) 0.77
Regular interval preventive pain relief compared with on demand treatment after hysterectomy. Pain (1985) 0.77
Succinylcholine neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase. Anesthesiology (1981) 0.77
[Research in Danish departments of anesthesiology at the turn of the century. A bibliometric analysis]. Ugeskr Laeger (2001) 0.77
The Sophus anaesthesia simulator v. 2.0. A Windows 95 control-center of a full-scale simulator. Int J Clin Monit Comput (1997) 0.77
The effect of peripheral hypothermia on a vecuronium-induced neuromuscular block. Acta Anaesthesiol Scand (1991) 0.77
Pretreatment with non-depolarizing muscle relaxants: the influence on neuromuscular transmission and pulmonary function. Acta Anaesthesiol Scand (1980) 0.77
Bispectral index monitoring: comparison of two types of electrode. Anaesthesia (2000) 0.77
Efficacy of the A-line AEP monitor as a tool for predicting successful insertion of a laryngeal mask during sevoflurane anesthesia. Acta Anaesthesiol Scand (2004) 0.77
Atracurium and its antagonism by neostigmine (plus glycopyrrolate) in patients susceptible to malignant hyperthermia. Br J Anaesth (1986) 0.77
Acceleromyography and mechanomyography for establishing potency of neuromuscular blocking agents: a randomized-controlled trial. Acta Anaesthesiol Scand (2009) 0.76
The inhibition of serum cholinesterase by urea. Mechanism of action and application in the typing of abnormal genes. Br J Anaesth (1977) 0.76
Analysis of anaesthesia in patients suspected to be susceptible to malignant hyperthermia before diagnostic in vitro contracture test. Acta Anaesthesiol Scand (1997) 0.76
Pharmacokinetics and pharmacodynamics of mivacurium in young adult and elderly patients. Acta Anaesthesiol Scand (2002) 0.76
Precurarization with vecuronium and pancuronium in awake, healthy volunteers: the influence on neuromuscular transmission and pulmonary function. Acta Anaesthesiol Scand (1985) 0.75